Best Practice & Research Clinical Haematology
Volume 21, Issue 4 , Pages 647-658, December 2008

Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?

  • Dan Douer, MD (Associate Professor of Medicine, Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Keck School of Medicine, Los Angeles, CA)

      Affiliations

    • Corresponding Author InformationTel.: +1 323 865 3950; Fax: +1 323 865 0060.

USC / Norris Cancer Center, 1441 Eastlake Ave Rm 3460, Los Angeles, CA 90033, United States

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(08)00070-4

doi:10.1016/j.beha.2008.08.004

Best Practice & Research Clinical Haematology
Volume 21, Issue 4 , Pages 647-658, December 2008

Article Tools

* Image Usage & Resolution